Albert Bourla

Pfizer CEO says tariff uncertainty is deterring further U.S. investment in manufacturing, R&D

by
Pfizer CEO says tariff uncertainty is deterring further U.S. investment in manufacturing, R&D

Albert Bourla, chairman and CEO of Pfizer, speaks at The Wall Street Journal’s Future of Everything Festival in New York City, U.S., May 22, 2024.  Andrew Kelly | Reuters Pfizer CEO Albert Bourla on Tuesday said uncertainty around President Donald Trump’s planned pharmaceutical tariffs is deterring the company from further investing in U.S. manufacturing and … Read more

Pfizer expands cost cuts, tops quarterly profit estimates even as sales fall

by
Pfizer expands cost cuts, tops quarterly profit estimates even as sales fall

The Pfizer logo is seen outside the pharmaceutical company’s manufacturing plant, in Newbridge, Ireland February 10, 2025.  Clodagh Kilcoyne | Reuters Pfizer on Tuesday expanded its cost-cutting efforts and reported first-quarter profit that topped estimates, even as the company’s sales fell, largely due to dwindling revenue for its antiviral Covid pill Paxlovid. The company previously … Read more